Search results
Eli Lilly Just Announced More Good News: Time to Buy?
Motley Fool via Yahoo Finance· 5 days agoMany of those that do earn approval end up falling short of sales expectations. However,...
Playbook: Kristi Noem shoots at ‘lone wolf’ Nikki Haley
Politico· 8 hours agoWith help from Eli Okun, Garrett Ross and Bethany Irvine WORTH YOUR TIME THIS MORNING — “What’s...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 1 day agoShares of Eli Lilly and Company (NYSE: LLY) have soared nearly 35% so far in 2024 and are only a few points away from doubling over the last 12 months....
Watch: Jennifer Lopez reluctantly teams up with AI in 'Atlas'
United Press International via Yahoo News· 3 hours agoThe streaming service shared a sneak peek of the sci-fi action thriller Friday featuring Jennifer...
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss...
Fortune· 8 hours agoIndianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as Type 2 diabetes drug but which has led to weight loss among patients, and ...
Despite 350% Rally, Novo Trades at Discount to Eli Lilly By Quiver Quantitative
Investing.com· 1 day agoAs the market dynamics shift, with both companies striving to capitalize on this...
Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?
Investor's Business Daily· 4 hours agoThe company is now planning multiple studies of MariTide in weight-loss and obesity-related...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks via Yahoo Finance· 3 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co (NYSE:LLY)
Benzinga· 1 day agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on Eli Lilly and Co LLY . And retail traders should know. We noticed this today when ...
Novo Nordisk, Eli Lilly drop on Amgen competition concerns By Investing.com
Investing.com· 7 hours agoShares of Novo Nordisk (NYSE:NVO) and Eli Lilly & Co. (NYSE:LLY) are down premarket Friday as competition in the GLP-1 market. Amgen (NASDAQ:AMGN) disclosed that it looked ...